Filtered By:
Cancer: Prostate Cancer

This page shows you your search results in order of relevance.

Order by Relevance | Date

Total 61 results found since Jan 2013.

Behind the Headlines 2014 Quiz of the Year
In 2014, Behind the Headlines covered more than 500 health stories that made it into the mainstream media. Test your knowledge of 2014's health news with our month-by-month quiz. If you've been paying attention, you should find this quiz both easy and fun. Answers are at the foot of the page (no peeking!).   In January 2014's health news... What was said to help make bones stronger? 1) Swimming 2) Marriage 3) Listening to classical music Warnings were issued about the possible return of what? 1) Swine flu 2) The Black Death 3) Smallpox   In February 2014's health news... What activity was said to lower your ...
Source: NHS News Feed - December 29, 2014 Category: Consumer Health News Tags: Special reports Medical practice Source Type: news

Abstracts of Presentations at the Association of Clinical Scientists 143 < sup > rd < /sup > Meeting Louisville, KY May 11-14,2022
Conclusion: These assays are suitable for routine diagnostic. The UltraFast NextGenPCR is the fastest with average time (30mins), followed by Agilent (2 hrs) and MassArray (6hrs). Upon completion of this activity, participants should be able to examine, measure and compare results from different assays for SARS detection, evaluate and diagnose accurately, as well as being able to plan, organize and recommend a diagnostic procedure for diagnostic laboratory. Key words: SARS-CoV-2, RNA extraction, RT-PCR, limit of detection, quantification cycle, COVID-19, in vitro diagnostic tests, Agilent, Massarray, Ultrafast. [20] From t...
Source: Annals of Clinical and Laboratory Science - July 1, 2022 Category: Laboratory Medicine Source Type: research

Electrochemical studies and spectroscopic investigations on the interaction of an anticancer drug flutamide with DNA and its analytical applications
Publication date: Available online 25 October 2014 Source:Journal of Electroanalytical Chemistry Author(s): Yassien Temerk , Hossieny Ibrahim Flutamide (Flu) is a chemotherapeutic drug, used for the treatment of prostate cancer. It functions by interfering DNA in fast growing cells and preventing them from reproducing. The present work is focused on the interaction of Flu with single and double stranded DNA at different temperatures and at physiological pH7.4 (human blood pH). Cyclic voltammetry, square wave voltammetry and UV-visible spectroscopy were used to analyze the interaction of Flu with DNA. The voltammetric res...
Source: Journal of Electroanalytical Chemistry - November 3, 2014 Category: Chemistry Source Type: research

Flutamide drug interaction studies on graphdiyne nanotube – a first-principles study
We report graphdiyne nanotube (Gdn-NT) as a drug carrier for flutamide (FLU) drug to the infected target cell, which is used to cure prostate cancer. In the present research work, first-principles studies were carried out for exploring the charge transfer, band gap, adsorption energy, and average band gap changes; upon interaction of FLU on Gdn-NT. In particular, we studied the solvent effect upon FLU adsorbed Gdn-NT in the report. These important parameters provide the perception of the interaction of the FLU drug onto Gdn-NT, and the favorable interaction sites of FLU on Gdn-NT are also studied. The novel aspects of the ...
Source: Computational and Theoretical Chemistry - September 24, 2019 Category: Chemistry Source Type: research

Flutamide-induced hepatotoxicity: ethical and scientific issues.
CONCLUSIONS: Scientific contributions highlight that FLU is responsible for specific hepatotoxic profiles in the female gender. From the ethical point of view, off-label prescribing of FLU in women is not only substantially unlawful, but also, without major safeguards being granted, a potential source of liability for prescribers. PMID: 28379593 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - April 7, 2017 Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research

Auger Radiopharmaceutical Therapy Targeting Prostate-Specific Membrane Antigen
Conclusion: PSMA-targeted radiopharmaceutical therapy with the Auger emitter 125I-DCIBzL yielded highly specific antitumor efficacy in vivo, suggesting promise for treatment of prostate cancer micrometastases.
Source: Journal of Nuclear Medicine - September 1, 2015 Category: Nuclear Medicine Authors: Kiess, A. P., Minn, I., Chen, Y., Hobbs, R., Sgouros, G., Mease, R. C., Pullambhatla, M., Shen, C. J., Foss, C. A., Pomper, M. G. Tags: Basic Science Investigations Source Type: research